Alina M. Allen, M.D.

  1. Gastroenterologist
  2. Internist

Publicaciones

  1. Dzyubak B, Li J, Chen J, Mara KC, Therneau TM, Venkatesh SK, Ehman RL, Allen AM, Yin M. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis. J Magn Reson Imaging. 2021 Feb 15 [Epub ahead of print]
    View PubMed
  2. Hagstrom H, Adams LA, Allen AM, Byrne CD, Chang Y, Gronbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J, Lazarus JV, Long MT, Loomba R, Newsome PN, Rowe IA, Ryu S, Schattenberg JM, Serper M, Sheron N, Simon TG, Tapper EB, Wild S, Wong VW, Yilmaz Y, Zelber-Sagi S, Aberg F. Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement. Hepatology. 2021 Jan 23 [Epub ahead of print]
    View PubMed
  3. Navin PJ, Gidener T, Allen AM, Yin M, Takahashi N, Torbenson MS, Kamath PS, Ehman RL, Venkatesh SK. The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):3051-3053.e2 Epub 2019 Oct 17
    View PubMed
  4. Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc. 2020 Dec; 95 (12):2612-2620
    View PubMed
  5. Gidener T, Ahmed OT, Larson JJ, Mara KC, Therneau TM, Venkatesh SK, Ehman RL, Yin M, Allen AM. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD. Clin Gastroenterol Hepatol. 2020 Sep 30 Epub 2020 Sept 30
    View PubMed
  6. Polonis K, Becari C, Chahal CAA, Zhang Y, Allen AM, Kellogg TA, Somers VK, Singh P. Chronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes. Sci Rep. 2020 Apr 22; 10 (1):6846
    View PubMed
  7. Yang JD, Ahmed F, Mara KC, Addissie BD, Allen AM, Gores GJ, Roberts LR. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology. 2020 Mar; 71 (3):907-916 Epub 2019 Oct 21
    View PubMed
  8. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology. 2020 Feb; 71 (2):510-521 Epub 2019 Mar 15
    View PubMed
  9. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Gunneson TJ, Ehman RL, Yin M. Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. Hepatol Commun. 2020 Feb; 4 (2):185-192 Epub 2019 Nov 05
    View PubMed
  10. Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. J Hepatol. 2019 Dec; 71 (6):1229-1236 Epub 2019 Aug 27
    View PubMed
  11. Ahmed OT, Allen AM. Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease A.M. Curr Hepatology Rep (2019). 2019.
  12. Allen AM, Therneau TM, Mara KC, Larson JJ, Watt KD, Hayes SN, Kamath PS. Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. Am J Gastroenterol. 2019 Nov; 114 (11):1764-1771
    View PubMed
  13. Martin Mateos R, Allen AM. Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. Rev Esp Enferm Dig 2019 Apr; 111 (4):253-255
    View PubMed
  14. Narayanan P, Mara K, Izzy M, Dierkhising R, Heimbach J, Allen AM, Watt KD. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Transplantation. 2019 Jan; 103 (1):e14-e21
    View PubMed
  15. Allen AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, McCoy RG. Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database. Hepatology. 2018 Dec; 68 (6):2230-2238 Epub 2018 Sept 20
    View PubMed
  16. Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, Therneau TM. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation. Transplantation. 2018 Oct; 102 (10):1710-1716
    View PubMed
  17. Welch BT, Schmitz JJ, Kurup AN, Atwell TD, Callstrom MR, Frey G, Paz-Fumagalli R, Allen A, Watt K, Heimbach J, Schmit GD. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdom Radiol (NY). 2018 Jun; 43 (6):1478-1481
    View PubMed
  18. Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. Hepatology. 2018 May; 67 (5):1726-1736 Epub 2018 Mar 23
    View PubMed
  19. Zhang Y, Somers KR, Becari C, Polonis K, Pfeifer MA, Allen AM, Kellogg TA, Covassin N, Singh P. Comparative Expression of Renin-Angiotensin Pathway Proteins in Visceral Versus Subcutaneous Fat. Front Physiol. 2018; 9:1370 Epub 2018 Oct 10
    View PubMed
  20. Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017 Dec; 66 (6):2055-2065 Epub 2017 Oct 30
    View PubMed
  21. Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol. 2017 May; 15 (5):767-775.e3 Epub 2016 Dec 21
    View PubMed
  22. Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016 Dec; 64 (6):2165-2172 Epub 2016 Oct 20
    View PubMed
  23. Allen AM, Kim WR. Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. Semin Liver Dis. 2016 May; 36 (2):123-6 Epub 2016 May 12
    View PubMed
  24. Malhi H, Allen AM, Watt KD. Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant. 2016 Apr; 21 (2):99-106
    View PubMed
  25. Allen AM, Kim WR, Larson JJ, Rosedahl JK, Yawn BP, McKeon K, Hay JE. The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol. 2016 Feb; 14 (2):287-94.e1-2 Epub 2015 Aug 21
    View PubMed
  26. Singh S, Khera R, Allen AM, Murad MH, Loomba R. Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis. Hepatology. 2015 Nov; 62 (5):1417-32 Epub 2015 Oct 01
    View PubMed
  27. Allen AM, Kim WR, Larson JJ, Colby C, Therneau TM, Rule AD. Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation. 2015 Jul; 99 (7):1431-5
    View PubMed
  28. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015 Apr; 13 (4):643-54.e1-9; quiz e39-40 Epub 2014 Apr 24
    View PubMed
  29. Allen AM, Kim WR, Heimbach JK, Rule AD. Reply to: Chronic Kidney Disease (CKD) and NAFLD: Time for hepatologists for awareness and screening J Hepatol.2014;pii:S0168-8278(14)00940-4.
  30. Allen AM, Hay JE. Review article: the management of cirrhosis in women. Aliment Pharmacol Ther. 2014 Nov; 40 (10):1146-54 Epub 2014 Sept 28
    View PubMed
  31. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK. Rule AD Reply to: Chronic Kidney Disease After Liver Transplantation Journal of Hepatology.2014;S0168-8278 (14)00706-5.
  32. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol. 2014 Aug; 61 (2):286-92 Epub 2014 Apr 05
    View PubMed
  33. Allen AM, Kim WR, Xiong H, Liu J, Stock PG, Lake JR, Chinnakotla S, Snyder JJ, Israni AK, Kasiske BL. Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant. 2014 May; 14 (5):1120-8 Epub 2014 Apr 14
    View PubMed
  34. Allen AM, Kim WR, Larson J, Loftus EV Jr. Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Dec; 11 (12):1655-60.e1 Epub 2013 July 23
    View PubMed
PST-20299342